The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study

Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders

(2022) Jan JGM Verschuuren et al.   LANCET NEUROLOGY

Prevalence and associated factors of fatigue in autoimmune myasthenia gravis.

(2021) Annabel M. Ruiter et al.   NEUROMUSCULAR DISORDERS

Gender differences in clinical outcomes in myasthenia gravis: A prospective cohort study

(2021) Jan L. S. Thomsen et al.   MUSCLE & NERVE

Accuracy of patient-reported data for an online patient registry of autoimmune myasthenia gravis and Lambert-Eaton myasthenic syndrome

(2021) Annabel M. Ruiter et al.   NEUROMUSCULAR DISORDERS

Fatigue in patients with myasthenia gravis. A systematic review of the literature

(2020) Annabel M. Ruiter et al.   NEUROMUSCULAR DISORDERS

Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature

(2019) André Farkouh et al.   ADVANCES IN THERAPY

Burden of illness in patients with treatment refractory myasthenia gravis

(2018) Nicole M. Engel-Nitz et al.   MUSCLE & NERVE

Ocular Myasthenia

(2018) Mohammed Al-Haidar et al.   NEUROLOGIC CLINICS

International consensus guidance for management of myasthenia gravis

(2016) Donald B. Sanders et al.   NEUROLOGY

EFNS/ENS Guidelines for the treatment of ocular myasthenia

(2014) E. Kerty et al.   EUROPEAN JOURNAL OF NEUROLOGY

Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis

(2007) Anna Rostedt Punga et al.   MUSCLE & NERVE